Hodgkin's disease: Correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with stage I supradiaphragmatic presentations vs. those in patients with stage II

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 2, 1998, Pages 377-386

  Fuller, Lillian M ^a   Mirza, Nadeem Q ^a   Palmer, J Lynn ^a   Davis, Barry R ^c   Ha , Chul S ^a   Rodriguez, M Alma ^a   Hagemeister, Fredrick B ^a   Cabanillas, Fernando ^a   McLaughlin, Peter ^a   Butler, James J ^a   North, Luceil B ^a   Martin, Richard G ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hodgkin's disease; Probabilities for negative abdominal studies

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; LAPAROTOMY; LYMPHANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ABDOMEN; ADULT; COHORT STUDIES; FEMALE; HODGKIN DISEASE; HUMANS; LAPAROTOMY; LYMPHOGRAPHY; MALE; NEOPLASM STAGING; PROBABILITY; SEX FACTORS; SPLEEN;

EID: 0032518470     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00712-8     Document Type: Article

References (40)

1. 1. Bergsagel, D. E.; Alison, R. E.; Bean, H. A.; Brown, T. C.; Bush, R. S.; Clark, R. M.; Chua, T.; Dalley, D.; DeBoer, G.; Gospodarowicz, M.; Hasselback, R.; Perrault, D.; Rideout, D. F. Results of treating Hodgkin's disease without a policy of laparotomy staging. Cancer Treat. Rep. 66:717-732; 1982.
2. 2. Boivin, J. F.; Hutchison, J. B.; Lubin, J. H.; Mauch, P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 69:1241-1247; 1992.
3. 3. Bonadonna, G. Modern treatment of malignant lymphomas: A multidisciplinary approach. Ann. Oncol. 5:5-16; 1994.
4. 4. Brice, P.; Tredaniel, J.; Mosuez, J. J.; Marolleau, J. P.; Ferme, C.; Hennequin, C.; Frija, J.; Gisselbrecht, C.; Boiron, M. Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's disease. Ann. Oncol. 2 (Suppl 2):73-76; 1991.
5. 5. Butler, J. J. The histologic diagnosis of Hodgkin's disease. Semin. Diagn. Pathol. 9:252-256; 1992.
6. 6. Carmel, R. J.; Kaplan, H. S. Mantle irradiation in Hodgkin's disease: An analysis of technique, tumor irradiation and complications. Cancer 37:2813-2825; 1976.
7. 7. Castellino, R. A.; Hoppe, R. T.; Blank, N.; Young, S. W.; Neumann, C.; Rosenberg, S. A.; Kaplan, H. S. Computed tomography, Iymphangiography and staging laparotomy: Correlations in initial staging of Hodgkin's disease. AJR 143:37-41; 1984.
8. 8. Cox, D. R.; Snell, E. J. The analysis of binary data, (2nd ed.). London: Chapman and Hall; 1989.
9. 9. Freeman, D. H., Jr. Applied categorical data analysis. New York: Marcel Dekker, Inc.; 1987.
10. 10. Fuller, L. M.; Gamble, J. F.; Shullenberger, C. C.; Butler, J. J.; Gehan, E. Prognostic factors in localized Hodgkin's disease treated with regional radiation. Radiology 98:641-654; 1971.
11. 11. Fuller, L. M.; Gamble, J. F.; Ibrahim, E.; Jing, B.; Butler, J. J.; Shullenberger, C. C. Stage II Hodgkin's disease: Significance of mediastinal and nonmediastinal presentations. Radiology 109:429-436; 1973.
12. 12. Givens, S. S.; Fuller, L. M.; Hagemeister, F. B.; Gehan, E. A. Treatment of lower torso Stages I and II Hodgkin's disease with radiation with or without adjuvant Mechlorethamine, Vincristine, Procarbazine, Prednisone. Cancer 66:69-74; 1990.
13. 13. Glatstein, E.; Guernsey, J. M.; Rosenberg, S. A.; Kaplan, H. S. The value of laparotomy and splenectomy in the staging of Hodgkin's disease. Cancer 24:709-718; 1969.
14. 14. Gospodarowicz, M. K.; Sutcliffe, S. B.; Clark, R. M.; Dembo, A. J.; Fitzpatrick, P. J.; Munro, A. J.; Bergsagel, D. E.; Patterson, B. J.; Tsang, R.; Chua, T.; Bush, R. S. Analyses of supradiaphragmatic clinical Stage I and II Hodgkin's disease treated with radiation alone. Int. J. Radiat. Oncol. Biol. Phys. 22:859-865; 1992.
15. 15. Hagemeister, F. B.; Fuller, L. M.; Sullivan, J. A.; North, L.; Butler, J. J.; Johnston, D.; Shullenberger, C. C. Stage I and II Hodgkin's disease: Involved field radiotherapy versus extended field radiotherapy, versus involved field followed by six cycles of MOPP. Cancer Treat. Rep. 66:789-798; 1982.
16. 16. Hagemeister, F. B.; Fuller, L. M.; Martin, R. G. Staging laparotomy: Findings and applications to treatment decisions. In. Fuller, L. M.; Hagemeister, F. B.; Sullivan, M. P.; Velasquez, W. S., eds. Hodgkin's disease and the nonHodgkin's lymphomas in adults and children. New York: Raven Press; 1988:170-185.
17. 17. Hagemeister, F. B.; Purugganan, R.; Fuller, L. M.; McLaughlin, P.; Swan, F., Jr.; Romaguera, J.; Rodriguez, M.; Cabanillas, F. Treatment of early stages of Hodgkin's disease with Novantrone, Vincristine, Vinblastine, Prednisone and radiotherapy. Semin. Hematol. 31:36-43; 1994.
18. 18. Hoppe, R. T.; Coleman, C. N.; Cox, R. S.; Rosenberg, S. A.; Kaplan, H. S. The management of Hodgkin's disease with irradiation alone or combined modality therapy. The Stanford experience. Blood 59:455-465; 1982.
19. 19. Ibrahim, E.; Fuller, L. M.; Gamble, J. F.; Jing, B.; Butler, J. J.; Gehan, E. Stage I Hodgkin's disease: Comparison of surgical staging with incidence of new manifestations in lymphangiogram and pre-lymphangiogram-studied patients. Radiology 104:145-151; 1972.
20. 20. Johnson, R. E. Is staging laparotomy routinely indicated in Hodgkin's disease? Ann. Intern. Med. 75:459-462; 1971.
21. 21. Keller, A. R.; Kaplan, H. S.; Lukes, R. T.; Rappaport, H. Correlation of histopathology with other prognostic indicators in Hodgkin's disease. Cancer 22:487-499; 1968.
22. 22. Koziner, B.; Myers, J.; Cirrincione, C.; Redman, J.; Cunningham, I.; Caravelli, J.; Nisce, L. Z.; McCormick, B.; Straus, D. J.; Mertelsmann, R.; Kempin, S.; Young, C. W.; Lee, B. J.; Clarkson, B. D. Treatment of Stages I and II Hodgkin's disease with three different therapeutic modalities. Am. J. Med. 80:1067-1087; 1986.
23. 23. Lee, C. K. K.; Bloomfield, C. D.; Levitt, S. H. Results of lung irradiation for Hodgkin's disease patients with large mediastinal and/or hilar disease. Cancer Treat. Rep. 66:819-826; 1982.
24. 24. Leslie, N. T.; Mauch, P. M.; Hellman, S. Stage IA to IIB supradiaphragmatic Hodgkin's disease: Long term survival and relapse frequency. Cancer 55:2072-2078; 1985.
25. 25. Mauch, P.; Goodman, R.; Hellman, S. The significance of mediastinal involvement in early Hodgkin's disease. Cancer 42:1029-1045; 1978.
26. 26. Mauch, P.; Larson, D.; Osteen, R.; Silver, B.; Yeap, B.; Canellos, R.; Weinstein, H.; Rosenthal, D.; Pinkus, G.; Jochelson, M.; Coleman, C. N.; Hellman, S. Prognostic factors for positive surgical staging in patients with Hodgkin's disease. J. Clin. Oncol. 8:257-265; 1990.
27. 27. Musshoff, K. Prognostic and therapeutic implications of staging in extranodal Hodgkin's disease. Conference on Staging in Hodgkin's disease. Ann Arbor, April 26-28, 1971. Cancer Res. 31:1814-1827; 1971.
28. 28. North, L. B.; Wallace, S.; Lendell, M. M., Jr.; Jing, B. S.; Fuller, L. M.; Allen, P. K. Lymphangiography for staging lymphomas; Is it still a useful procedure. AJR 161:867-869; 1993.
29. 29. Peters, M. V. A study of survivals in Hodgkin's disease treated radiologically. AJR 63:299-311; 1950.
30. 30. Rodriguez, M. A.; Fuller, L. M.; Zimmerman, S. O.; Allen, P. K.; Brown, B. W.; Munsell, M. F.; Hagemeister, F. B.; McLaughlin, P.; Velasquez, W. S.; Swan, F., Jr.; Cabanillas, F. F. Hodgkin's disease: Study of treatment intensities and incidences of second malignancies. Ann. Oncol. 4:125-131; 1993.
31. 31. Rosenberg, S. A.; Kaplan, H. S. The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease, 1962-1984. Int. J. Radiat. Oncol. Biol. Phys. 11:5-22; 1985.
32. 32. Rosenberg, S. A. The treatment of Hodgkin's disease. Ann. Oncol. 5 (Suppl 2):S17-S21; 1994.
33. 33. SAS Institute Inc. SAS/STAT user's guide, version 6, fourth ed., vols. 1-2. Cary NC: SAS Institute Inc.; 1989.
34. 34. Sombeck, M. D.; Mendenhall, N. P.; Kaude, J. V.; Torres, G. M.; Million, R. R. Correlation of lymphangiography, computed tomography, and laparotomy in the staging of Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 25:425-429; 1993.
35. 35. Stein, R. S.; Golomb, H. M.; Wieraik, P. H.; Mauch, P.; Hellman, S.; Ultmann, J. E.; Rosenthal, D. S.; Flexner, J. M. Anatomic substages of Stage IIIA Hodgkin's disease: Follow-up of a Collaborative Clinical Trial. Cancer Treat. Rep. 66:733-742; 1982.
36. 36. Sutcliffe, S. B.; Gospodarowicz, M. K.; Bergsagel, D. E.; Bush, R. S.; Alison, R. E.; Bean, H. A.; Brown, T. C.; Chua, T.; Clark, R. M.; Curtis, J. E.; Dembo, A. J.; Fitzpatrick, P. J.; Hasselback, R. H.; Rideout, D. F.; Sturgeon, J. F. G.; Quirt, I.; Yeoh, L.; Peters, M. V. Prognostic groups for management of localized Hodgkin's disease. J. Clin. Oncol. 3:393-401; 1985.
37. 37. Thar, T. L.; Million, R. R.; Hausner, R. J.; McKetty, M. H. B. Hodgkin's disease Stage I and II: Relationship of recurrence to size of disease, radiation alone, and number of sites involved. Cancer 43:1101-1105; 1979.
38. 38. Tubiana, M.; Henry-Amar, M.; Hyat, M.; Burgers, M.; Qasim, M.; Somers, R.; Sizoo, W.; van der Schueren, E. Prognostic significance of the number of involved areas in the early stages of Hodgkin's disease. Cancer 54:885-894; 1984.
39. 39. Valagusa, P.; Santoro, A.; Fossat-Bellami, P.; Banfi, A.; Bonadonna, G. Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J. Clin. Oncol. 4:830-837; 1986.
40. 40. Wallace, S.; Jackson, L.; Schaffer, B.; Gould, J.; Greening, R. R.; Weiss, A.; Kramer, S. Lymphangiograms: Their diagnostic and therapeutic potential. Radiology 76:179-199; 1961.